Evidence map›Paper›PMID 27057905›Full record

ArticleMedicine2016

Enlarging Red Blood Cell Distribution Width During Hospitalization Identifies a Very High-Risk Subset of Acutely Decompensated Heart Failure Patients and Adds Valuable Prognostic Information on Top of Hemoconcentration.

João Pedro Ferreira, Nicolas Girerd, Mattia Arrigo, Pedro Bettencourt Medeiros, Miguel Bento Ricardo, Tiago Almeida, Alexandre Rola, Heli Tolpannen, Said Laribi, Etienne Gayat and 5 more

Erratum issuedOpen access · goldAbstract readMulticenter Study
In one paragraph

Article in Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Prognostic value of estimated plasma volume in acute heart failure in three cohort studies.Clinical research in cardiology : official journal of the German Cardiac Society · 2019
    Article
  10. Observational
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

João Pedro FerreiraFrom the INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERMU1116, Université de Lorraine, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France (JPF, NG, FZ, PR); Department of Physiology and Cardiothoracic Surgery, Cardiovascular Research and Development Unit, Faculty of Medicine, University of Porto, Porto, Portugal (JPF); INSERM UMR-S 942, APHP Lariboisière University Hospital, F-CRIN INI-CRCT, Paris, France (MA, AR, HT, SL, EG, AM); Internal Medicine Department, Centro Hospitalar do Porto, Porto, Portugal (PBM, MBR, TA); Department of Anesthesiology and Critical Care Medicine, Saint Louis Lariboisière University Hospital, Assistance Publique - Hôpitaux de Paris; Université Paris Diderot, Paris, France (EG, AM); Cardiovascular Research Institute Basel (CRIB), University Hospital, Basel, Switzerland (CM); and Department of Cardiology, University Hospital, Basel, Switzerland; Intensive Care Unit, Centro Hospitalar do Porto, Porto, Portugal (IA).
Nicolas Girerd
Mattia Arrigo
Pedro Bettencourt Medeiros
Miguel Bento Ricardo
Tiago Almeida
Alexandre Rola
Heli Tolpannen
Said Laribi
Etienne Gayat
Alexandre Mebazaa
Christian Mueller
Faiez Zannad
Patrick Rossignol
Irene Aragão
Hôpital Lariboisière · FRCentre d'Investigation Clinique Pierre Drouin · FRCentro Hospitalar do Porto · PTAssistance Publique – Hôpitaux de Paris · FRInserm · FRUniversity Hospital of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Red blood cell distribution width (RDW) may serve as an integrative marker of pathological processes that portend worse prognosis in heart failure (HF). The prognostic value of RDW variation (ΔRDW) during hospitalization for acute heart failure (AHF) has yet to be studied.We retrospectively analyzed 2 independent cohorts: Centro Hospitalar do Porto (derivation cohort) and Lariboisière hospital (validation cohort). In the derivation cohort a total of 170 patients (age 76.2 ± 10.3 years) were included and in the validation cohort 332 patients were included (age 76.4 ± 12.2 years). In the derivation cohort the primary composite outcome of HF admission and/or cardiovascular death occurred in 78 (45.9%) patients during the 180-day follow-up period.Discharge RDW and ΔRDW were both increased when hemoglobin levels were lower; peripheral edema was also associated with increased discharge RDW (all P < 0.05). Discharge RDW value was significantly associated with adverse events: RDW > 15% at discharge was associated with a 2-fold increase in event rate, HR = 1.95 (1.05-3.62), P = 0.04, while a ΔRDW >0 also had a strong association with outcome, HR = 2.47 (1.35-4.51), P = 0.003. The addition of both discharge RDW > 15% and ΔRDW > 0 to hemoconcentration was associated with a significant improvement in the net reclassification index, NRI = 18.3 (4.3-43.7), P = 0.012. Overlapping results were found in the validation cohort.As validated in 2 independent AHF cohorts, an in-hospital RDW enlargement and an elevated RDW at discharge are associated with increased rates of mid-term events. RDW variables improve the risk stratification of these patients on top of well-established prognostic markers.

Indexed as

Erythrocyte IndicesHospitalizationAcute DiseaseAgedCohort StudiesErythrocyte CountFemaleFollow-Up StudiesHeart FailureHumansMalePrognosisRetrospective StudiesRisk Assessment

Identifiers

PMID27057905
PMCPMC4998821
OpenAlexW2340598109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.